文献速递外周动脉疾病

球囊扩张支架与自膨式支架治疗股总动脉狭窄的评估

Evaluation of balloon and self-expandable stents for common femoral artery stenosis.
PubMed 文献 · J Vasc Surg · 2024-09-23

本研究纳入2016至2022年连续90例股总动脉及分叉狭窄手术,比较自膨式支架(SES,26例)与球囊扩张支架(BES,64例)。12个月一期通畅率SES 88%对BES 72%(P=0.10),免于靶病变血运重建率SES 97%对BES 81%(P=0.13)。SES呈现更好趋势,但需对照研究进一步验证。

要点

  • 股总动脉分叉狭窄连续纳入90例手术(SES 26例、BES 64例)。
  • 12个月一期通畅率SES 88%、BES 72%(P=0.10)。
  • 12个月免于TLR率SES 97%、BES 81%(P=0.13)。

核心结论

  • SES治疗股总动脉狭窄在12个月通畅率和免于TLR率上呈现优于BES的趋势。
  • 作者认为需要对照研究进一步探究该趋势的意义。

研究设计与样本

  • 连续纳入2016至2022年股总动脉及分叉狭窄患者,按植入支架类型分组。
  • 共纳入77例患者的90例手术,SES组26例、BES组64例。

主要发现

  • Rutherford分级以2级(28%)、3级(48%)、4级(8%)最常见。
  • Azema分型两组可比:SES/BES 2型31%/27%,3型54%/62%。
  • 12个月一期通畅率SES 88%(26/26例)对BES 72%(58/64例),P=0.10。
  • 12个月免于TLR率SES 97%对BES 81%,P=0.13。

关键数值与推荐

  • 一期通畅定义为双功超声收缩期峰值流速比≤2.4且无临床驱动的靶病变血运重建或旁路手术。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endovascular treatment of the common femoral artery (CFA) and its bifurcation is currently recommended for patients with hostile groin (prior femoral bifurcation open surgery, history of radiotherapy) or severe comorbidities (advanced age, frailty, obesity). Preliminary results have shown favorable outcomes. Among the different endovascular techniques (atherectomy, intravascular lithotripsy, plain balloon angioplasty, drug-coated balloon angioplasty, stenting), stents are mainly used but the best type of stent to use is still debated. The aim of this study was to assess the value of balloon-expandable stents (BES) and self-expandable stents (SES) for stenosis of the femoral bifurcation. METHODS: Consecutive patients with stenosis of the CFA and its bifurcation were included from 2016 to 2022. Demographic data, the type of stent used, procedural data, and angiographic variables were collected. Groups were defined according to the type of stent implanted. Primary patency was defined as a binary end point based on a duplex ultrasound peak systolic velocity ratio of ≤2.4 as assessed by duplex ultrasound examination, in the absence of clinically driven target lesion revascularization (TLR) or bypass of the target lesion. Secondary outcomes were clinical sustained improvement, freedom from TLR at 12 months, mean ankle-brachial index improvement, primary-assisted patency, and secondary patency. RESULTS: A total of 90 procedures conducted in 77 patients were included in this study, 26 in the SES group and 64 in the BES group. The most common symptomatology according to the Rutherford classification was class 2, 3, and 4 (28%, 48%, and 8%, respectively). The type of lesions in the CFA, assessed using the Azema classification, were comparable between both groups (SES/BES group type 2: 31%/27%; type 3: 54%/62%). At 12 months, the primary patency rates for SES and BES were 88% (26/26 patients) and 72% (58/64 patients) (P = .10). At 12 months, freedom from TLR rates for SES and BES were 97% vs 81%, respectively (P = .13). CONCLUSIONS: SES for CFA stenosis show a trend toward better patency and freedom from TLR rates at 12 months. However, controlled studies are warranted to further investigate the significance of this trend.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Bamdé CC, Goueffic Y, Blitti C, et al. Evaluation of balloon and self-expandable stents for common femoral artery stenosis. J Vasc Surg. 2024. PMID: 39321897. doi:10.1016/j.jvs.2024.09.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。